Trials / Unknown
UnknownNCT03600688
Edwards Cardioband European Post-Market Study, MiBAND
Transcatheter Repair of Mitral Regurgitation With Cardioband System Post Market Study:A European Prospective, Multicenter Study to Assess Transcatheter Mitral Valve Repair With Edwards Cardioband System in Patients With Symptomatic MR
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 200 (estimated)
- Sponsor
- Edwards Lifesciences · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To demonstrate reduction of MR with durable performance and im-provements in functional status
Detailed description
MiBAND is a prospective, single arm, European post-market study to assess the safety and efficacy of the Edwards Cardioband system. Patients will be followed up at 30D, 6months, 1, 2 and 3 years.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Edwards Cardioband System | Transcatheter mitral valve repair |
Timeline
- Start date
- 2018-06-06
- Primary completion
- 2023-12-30
- Completion
- 2023-12-31
- First posted
- 2018-07-26
- Last updated
- 2023-01-26
Locations
17 sites across 3 countries: Germany, Italy, Switzerland
Source: ClinicalTrials.gov record NCT03600688. Inclusion in this directory is not an endorsement.